Prize Medal Lecture to be given by Dr Christof Fellmann
13 February 2019
The 2019 Prize Medal has been awarded to Professor Jennifer Doudna, University of California, Berkeley, in recognition of her ground breaking contributions using the CRISPR-Cas system in gene editing. In Belfast this April her award will be accepted on her behalf by Dr Christof Fellmann, Assistant Adjunct Professor at the School of Medicine, University of California, San Francisco and Staff Research Investigator, Gladstone Institutes.
As a former postdoctoral fellow and NIH Pathway to Independence awardee in Professor Doudna’s laboratory, Dr Fellmann will give the Prize Medal Lecture, providing delegates with an insight into his work which focuses on advancing precision medicine, including novel genome surgery approaches, for the treatment of human disease.
© Keegan Houser, UC Berkeley
With a background in molecular biology and biotechnology engineering, Dr Fellmann is also a co-founder and former Chief Scientific Officer of Mirimus, a start-up company developing genetically engineered mouse models of human disease for early-stage drug discovery. Dr Fellmann’s work aims at better understanding the plasticity of signaling networks in disease, and to establish novel treatment for patients, by developing and applying transformative CRISPR-Cas and RNAi systems, with a particular focus on RAS-mutant and TERT-promoter mutant cancer.
The Prize Medal Lecture will take place at 9:00 on Tuesday 9 April in the Main Auditorium. Early bird registration for the Annual Conference is open until 4 March – find out more on the Annual Conference page.
Image: Dr Christof Fellman.
